Impact of Heart Rate on Central Aortic Pressures and Hemodynamics. Analysis From the CAFE (Conduit Artery Function Evaluation) Study: CAFE-Heart Rate

Journal of the American College of Cardiology

Volumn 54, Issue 8, 2009, Pages 705-713

  Williams, Bryan ^a   Lacy, Peter S ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

beta blocker; central aortic pressure; heart rate; hypertension

Indexed keywords

AMLODIPINE; ATENOLOL; BENDROFLUMETHIAZIDE; PERINDOPRIL;

ADULT; AGED; ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; AORTA PRESSURE; ARTICLE; AUGMENTATION INDEX; BETA ADRENERGIC RECEPTOR BLOCKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART RATE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPEN STUDY; PRIORITY JOURNAL; PULSE PRESSURE; PULSE WAVE; RADIAL ARTERY; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANTIHYPERTENSIVE AGENTS; AORTA; BLOOD PRESSURE; BRACHIAL ARTERY; FEMALE; HEART RATE; HEMODYNAMICS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; SYSTOLE;

EID: 65649153181     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.02.088     Document Type: Article

References (38)

1. Lindholm L.H., Carlberg B., and Samuelsson O. Should beta blockers remain first choice in the treatment of primary hypertension?. A meta-analysis. Lancet 366 (2005) 1545-1553
2. Wiysonge C., Bradley H., Myose B., et al. Beta-blockers for hypertension. Cochrane Data Base Syst Rev 1 (2007) CD002003
3. Bangalore S., Wild D., Parkar S., Kukin M., and Messerli F.H. Beta-blockers for primary prevention of heart failure in patients with hypertension. J Am Coll Cardiol 52 (2008) 1062-1072
4. Bangalore S., Sawhney S., and Messerli F.H. Relation of β-blocker-induced heart rate lowering and cardioprotection in hypertension. J Am Coll Cardiol 52 (2008) 1482-1489
5. Williams B. β-blockers and the treatment of hypertension. J Hypertens 25 (2007) 1351-1353
6. NICE/BHS. Clinical guideline 34: hypertension: management of hypertension in adults in primary care: partial update. http://www.nice.org.uk/CG034guidance Accessed March 10, 2007
7. The CAFE Investigators for the ASCOT Investigators. Differential impact of blood pressure lowering drugs on central aortic pressure and clinical outcomes-principal results of the Conduit Artery Function Evaluation study: the CAFE study. Circulation 113 (2006) 1213-1225
8. Chen C.-H., Ting C.-T., Lin S.-J., et al. Different effects of fosinopril and atenolol on wave reflections in hypertensive patients. Hypertension 25 (1995) 1034-1041
9. Hirata K., Vlachopoulos C., Adji A., and O'Rourke M. Benefits from angiotensin-converting enzyme inhibitor 'beyond blood pressure lowering': beyond blood pressure or beyond the brachial artery?. [erratum in: J Hypertens 2005;23:903-4]. J Hypertens 23 (2005) 551-556
10. London G.M., Asmar R.G., O'Rourke M., Safar M.E., and REASON Investigators. Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: comparison with atenolol. J Am Coll Cardiol 43 (2004) 92-99
11. Deary A.J., Schumann A.L., Murfet H., Haydock S., Foo R.S., and Brown M. Influence of drugs and gender on the arterial pulse wave and natriuretic peptide secretion in untreated patients with essential hypertension. Clin Sci 103 (2002) 493-499
12. Wilkinson I.B., MacCallum H., Flint L., Cockcroft J.R., Newby D.E., and Webb D.J. The influence of heart rate on augmentation index and central arterial pressure in humans. J Physiol 525 (2000) 263-270
13. Wilkinson I.B., Mohammed N.H., Tyrrell S., et al. Heart rate dependency of pulse pressure amplification and arterial stiffness. Am J Hypertens 15 (2002) 24-30
14. Dahlof B., Sever P.S., Poulter N.R., et al., ASCOT Investigators. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 366 (2005) 895-906
15. Sever P.S., Dahlof B., Poulter N.R., et al., ASCOT Investigators. Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial. J Hypertens 19 (2001) 1139-1147
16. Kelly R., Hayward C.S., and Ganis J. Non-invasive registration of the arterial pressure pulse waveform using high-fidelity applanation tonometry. J Vasc Biol 1 (1989) 142-149
17. O'Rourke M., and Gallagher D.E. Pulse wave analysis. J Hypertens 14 Suppl 5 (1996) S147-S157
18. Chen C.-H., Nevo E., Fetics B., et al. Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure: validation of generalized transfer function. Circulation 95 (1997) 1827-1836
19. Fetics B., Nevo E., Chen C.-H., and Kass D.A. Parametric model derivation of transfer function for non-invasive estimation of aortic pressure by radial tonometry. IEEE Trans Biomed Eng 46 (1999) 698-706
20. Siebenhofer A., Kemp C.R.W., Sutton A.J., and Williams B. The reproducibility of central aortic blood pressure measurements in healthy subjects using applanation tonometry and sphygmocardiography. J Hum Hypertens 13 (1999) 625-629
21. Laurent P., Albaladejo P., Blacher J., Rudnichi A., Smulyan H., and Safar M.E. Heart rate and pulse pressure amplification in hypertensive subjects. Am J Hypertens 16 (2003) 363-370
22. McEniery C.M., Yasmin, Hall I.R., et al., ACCT Investigators. Normal vascular aging; differential effects on wave reflections and aortic pulse wave velocity. The Anglo Cardiff Collaborative Trial (ACCT). J Am Coll Cardiol 46 (2005) 1753-1760
23. Savoia C., Touyz R.M., Endemann D.H., et al. Angiotensin receptor blocker added to previous antihypertensive agents on arteries of diabetic hypertensive patients. Hypertension 48 (2006) 271-277
24. Asmar R.G., London G.M., O'Rourke M., Safar M.E., and REASON Project Coordinators and Investigators. Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patients: a comparison with atenolol. Hypertension 38 (2001) 922-926
25. O'Rourke M. Arterial stiffness, systolic blood pressure, and logical treatment of arterial hypertension. Hypertension 15 (1990) 339-347
26. Nichols W.W., and Edwards D.G. Arterial elastance and wave reflection augmentation of systolic blood pressure: deleterious effects and implications for therapy. J Cardiovasc Pharmacol Therapeut 6 (2001) 5-21
27. Edwards D.G., and Lang J.T. Augmentation index and systolic load are lower in competitive endurance athletes. Am J Hypertens 18 (2005) 679-683
28. Roman M.J., Devereux R.B., Kizer J.R., et al. Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Heart study. Hypertension 50 (2007) 197-203
29. Jankowski P., Kawecka-Jaszcz K., Czarnecka D., et al. Pulsatile but not steady component of blood pressure predicts cardiovascular events in coronary patients. Hypertension 51 (2008) 848-855
30. Ting C.-T., Chen C.-H., Chang M.-S., and Yin F.C.P. Short- and long-term effects of antihypertensive drugs on arterial reflections, compliance and impedance. Hypertension 26 (1995) 524-530
31. Kelly R., Daley J., Avolio A., and O'Rourke M. Arterial dilation and reduced wave reflection. Benefit of dilevanol in hypertension. Hypertension 14 (1989) 14-21
32. Dhakam Z.Y., McEniery C.M., Burton T., Brown M.J., and Wilkinson I.B. A comparison of atenolol and nebivolol in isolated systolic hypertension. J Hypertens 26 (2008) 351-356
33. Ting C.T., Chou C.Y., Chang M.S., Wang S.P., Chiang B.N., and Yin F.C.P. Arterial hemodynamics in human hypertension: effects of adrenergic blockade. Circulation 84 (1991) 1049-1057
34. Protogerou A.D., Blacher J., Mavrikakis M., Lekakis J., and Safar M.E. Increased pulse pressure amplification in treated hypertensive subjects with metabolic syndrome. Am J Hypertens 20 (2007) 127-133
35. Safar M.E., Blacher J., Protogerou A.D., and Achimastos A. Arterial stiffness and central hemodynamics in treated hypertensive subjects according to brachial blood pressure classification. J Hypertens 26 (2008) 130-137
36. Dyer A.R., Persky V., Stamler J., et al. Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies. Am J Epidemiol 112 (1980) 736-749
37. Gillum R.F., Makuc D.M., and Feldman J.J. Pulse rate, coronary heart disease and death: the NHANES I epidemiologic follow-up study. Am Heart J 121 (1991) 172-177
38. Palatini P., Thijs L., Staessen J.A., et al., Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Predictive value of clinic and ambulatory heart rate for mortality in elderly subjects with systolic hypertension. Arch Intern Med 162 (2002) 2313-2321